首页> 外文期刊>Pharmacological research: The official journal of The Italian Pharmacological Society >Effect of route of administration on the disposition of acrylonitrile: quantitative whole-body autoradiographic study in rats.
【24h】

Effect of route of administration on the disposition of acrylonitrile: quantitative whole-body autoradiographic study in rats.

机译:给药途径对丙烯腈处置的影响:大鼠全身放射自显影定量研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Previous studies on the effect of route of administration on acrylonitrile (VCN) toxicity in animal models indicated high rates of metabolism in rats that received an oral dose than those received an i.p. VCN dose. To evaluate the role of route of administration on the distribution of VCN, a quantitative whole-body autoradiography (QWBA) and elimination studies were conducted. Equimolar doses of 2-[14C]-VCN were administered i.v. or p.o. to male Fischer (F-344) rats. Time course of QWBA indicated a higher retention and covalent interaction of radioactivity in the liver, spleen and bone marrow of rats received an i.v. dose of 2-14C-VCN than those received a p.o. dose. Unlike rats that received an i.v. dose of VCN, the animals received an oral dose showed a high retention of 14C in blood, stomach and gastric mucosa. Differences were also reflected in 14C elimination in urine, feces and expired air. Animals treated orally with 2-[14C]-VCN excreted 61% of the administered radioactive dose (4% in expired air, 4% in urine and 53% in feces). Rats that received an i.v. dose of 2-[14C]-VCN, however, eliminated only 30% of the total radioactive dose (expired air 2%, urine 8% and feces 21%). The results indicate that metabolism, detoxication and elimination of VCN are more pronounced following oral administration as compared to i.v. route of administration. The study also demonstrates that the systemic administration of VCN enhances its covalent interaction and retention in the tissues thus cause more toxicity in these organs.
机译:先前在动物模型中对给药途径对丙烯腈(VCN)毒性的影响的研究表明,口服给药的大鼠的代谢率高于经腹膜内给药的大鼠。 VCN剂量。为了评估给药途径对VCN分布的作用,进行了定量全身放射自显影(QWBA)和消除研究。静脉内注射等摩尔剂量的2- [14C] -VCN。或p.o.给雄性Fischer(F-344)大鼠。 QWBA的时程表明接受静脉内注射的大鼠在肝脏,脾脏和骨髓中具有较高的放射性保留和共价相互作用。剂量为2-14C-VCN,比接受p.o.剂量。不像接受静脉注射的老鼠接受VCN剂量的动物,口服剂量在血液,胃和胃粘膜中显示14C的高度保留。尿,粪便和呼出空气中14 C的消除也反映出差异。口服2- [14C] -VCN处理的动物排泄了61%的放射性剂量(4%在呼出空气中,4%在尿液中和53%在粪便中)。接受静脉注射的大鼠但是,使用2- [14C] -VCN的剂量只消除了总放射性剂量的30%(空气2%,尿8%和粪便21%)。结果表明,与静脉注射相比,口服给药后VCN的代谢,解毒和消除更为明显。管理途径。该研究还表明,VCN的全身给药可增强其共价相互作用和在组织中的保留,从而在这些器官中引起更多毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号